Which is better, CME or EVR?

On the Buffett-Fit framework, CME Group Inc. (CME) currently grades higher than EVR — 70/100 (B grade) vs 71/100 (B). That said, "better" depends on which framework you trust — CME wins on Philip Fisher, Peter Lynch, and Joel Greenblatt; EVR wins on Warren Buffett, Benjamin Graham, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy CME or EVR?

This page is an educational comparison, not investment advice. Both CME and EVR are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is CME better than EVR for value investing?

The two are close on the headline Buffett-Fit score (70/100 vs 71/100), so "better for value investing" depends on which pillar you weight most. The five Buffett pillars + six other frameworks are broken down side-by-side on this page so you can pick the one that fits your style.

What's the difference between CME and EVR on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). CME currently scores 70/100 (B grade); EVR scores 71/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, CME or EVR?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. CME and EVR are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, CME or EVR?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are CME and EVR both Financial Services stocks?

Yes — both CME Group Inc. (CME) and Evercore Inc. (EVR) operate in the Financial Services sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this CME vs EVR comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

CME Group

Evercore

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

CME

CME Group

Market cap

$105.53B

Sector

Financials

EVR

Evercore

Market cap

$13.39B

Sector

Financials

Overall winner

CME Group CME

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	CME	EVR	Winner
Warren Buffett	70B	71B	EVR
Benjamin Graham	69B	74B	EVR
Philip Fisher	67B	49D	CME
Peter Lynch	61C	26F	CME
Joel Greenblatt	53C	45D	CME
Charlie Munger	55D	69C	EVR
Terry Smith	57D	66B	EVR

Side-by-side metrics

Metric	CME	EVR
Market cap	$105.53B	$13.39B
P/E (TTM)	25.3x	17.4x
EV/EBIT	25.8x	16.1x
ROIC (TTM)	9.36%	20.1%
Gross margin	86.34%	98.95%
Net margin	62.77%	16.3%
Revenue CAGR 5y	8.59%	4.08%
EPS CAGR 5y	11.24%	-4.63%
Debt / Equity	0.1x	0.6x
Dividend yield	3.75%	1.01%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

CME leads on

EPS CAGR 5y11.24%vs -4.63%+141%
Market cap$105.53Bvs $13.39B+87%
Debt / Equity0.1xvs 0.6x+79%
Net margin62.77%vs 16.3%+74%

EVR leads on

ROIC (TTM)20.1%vs 9.36%+53%
EV/EBIT16.1xvs 25.8x+38%
P/E (TTM)17.4xvs 25.3x+31%
Gross margin98.95%vs 86.34%+13%

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

CME Group

Evercore

Fit scores by strategy

Side-by-side metrics

Where each one wins

More like CME

More like EVR

Related on invest-like

Key terms in this analysis